Peter R. Dolan
http://dbpedia.org/resource/Peter_R._Dolan an entity of type: Thing
Peter R. Dolan (born January 6, 1956) is an American business executive. In 2009, he became chairman and CEO of after joining the board in July 2008; he was formerly the chief executive officer of Bristol-Myers Squibb before being discharged from that company in September 2006 as a result of a federal investigation into questions concerning the patent of drug Plavix.
rdf:langString
rdf:langString
Peter R. Dolan
rdf:langString
Peter R. Dolan
rdf:langString
Peter R. Dolan
xsd:date
1956-01-06
xsd:integer
22370779
xsd:integer
1112382018
rdf:langString
Tuck School of Business, 1980 (M.B.A.)
rdf:langString
Tufts University, 1978 (B.A.)
xsd:date
1956-01-06
xsd:integer
2
rdf:langString
American
rdf:langString
Chief executive officer of Gemin X Pharmaceuticals
rdf:langString
Lois Burkhart and John Ralph Dolan
rdf:langString
Katherine Helen Lange
rdf:langString
Peter R. Dolan (born January 6, 1956) is an American business executive. In 2009, he became chairman and CEO of after joining the board in July 2008; he was formerly the chief executive officer of Bristol-Myers Squibb before being discharged from that company in September 2006 as a result of a federal investigation into questions concerning the patent of drug Plavix.
xsd:nonNegativeInteger
9060
xsd:gYear
1956